The Johnson & Johnson company, accelerated the outbreak of the first human testing of a vaccine from COVID-19. Originally it was planned to start in September, but now this date is postponed to the second half of July, says on the company website.
The testing will take part 1045 healthy people aged 18 to 55 years. The study will take place in the United States and Belgium.
If the research will be successful and will show that the vaccine is safe and effective, the company will supply more than 1 billion doses worldwide for 2021.
Johnson & Johnson is an American holding company that heads a group of more than 250 subsidiaries worldwide, producing medicines, hygiene products and medical equipment.
Who believe that the coronavirus would pose a serious threat, until they invent a vaccine. According to the head of the European Agency of medicines Marco Kavaleri, in the best case, the vaccine will be ready next year.
May 15, U.S. President Donald trump said that the coronavirus vaccine may be ready by the end of the year.
May 19, the US announced the successful testing of vaccines against coronaviruses in humans.
Flash coronavirus infection COVID-19 began in late 2019 in China. March 11, 2020, the world health organization declared the spread of the coronavirus pandemic.